Global Antiemetics
Market Report
2024
Antiemetics Market Report 2024 (Global Edition)
Delivery Includes:- Market Timeline 2019 till 2031, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Antiemetics Market Report 2024.
Global Antiemetics Market Report 2024 Market Size Split by Drug Type (Serotonin-Receptor Antagonists, Dopamine Receptor Antagonists), by Application (Gastroenteritis, Post-Operative Surgery, Chemother...
According to cognitive market research, the global antiemetics market size was valued at USD xx billion in 2024 and is expected to reach USD xx billion at a CAGR of xx% during the forecast period.
- The drugs or medications which help to prevent and treat conditions such as nausea, and vomiting are referred to as antiemetic drugs.
- North America dominated the market with a share of xx% in 2024. The existence of major companies like Pfizer and GSK plc is probably going to increase the region's revenue share.
- The Asia Pacific market is expected to grow at a significant CAGR from 2024 to 2031. The region's market is anticipated to be supported by rising cancer and gastroenteritis incidence rates as well as the expanding availability of antiemetics.
- The Middle East and Africa market is expanding as a result of the rapidly ageing population and an increase in cancer patients.
- Leading players in the market are constantly involved in a range of strategic activities designed to maintain and strengthen their position within the industry.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Market Size | 121212 |
| Country Market Size | 121212 |
| North Americ Market Size | 121212 |
| Europe Market Size | 121212 |
| Asia Pacific Market Size | 121212 |
| South America Market Size | 121212 |
| Middle East and Africa Market Size | 121212 |
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
| |
| Market Split by Drug Type |
|
| Market Split by Application |
|
| Market Split by End-User |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Antiemetics industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Antiemetics Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Antiemetics Market Report Description
Introduction of the Antiemetics Market
The drugs or medications which help to prevent and treat conditions such as nausea, and vomiting are referred to as antiemetic drugs. Motion sickness and vertigo are two conditions that might induce emesis. Moreover, antiemetics can be used to treat or prevent the adverse effects of chemotherapy, such as nausea and vomiting. Moreover, these antiemetic medications are widely used in the medical field and fall into many types, including neurokinin receptor antagonists, dopamine receptor antagonists, and serotonin receptor antagonists. These medications can also be used to treat vomiting brought on by several illnesses, such as food poisoning, pregnancy, dizziness, general anaesthesia, opioid analgesics, gastroenteritis, and others.
Furthermore, a typical ailment known as "morning sickness" during pregnancy includes nausea and vomiting. During pregnancy, nausea and vomiting often don't harm the foetus, although they might interfere with daily tasks. According to the American Academy of Family Physicians (AAFP), around 75% of pregnant women experience nausea and vomiting, and 1% of women have hyperemesis gravidarum, which can have harmful effects on both the mother and the foetus. Unwanted consequences from the use of drugs to prevent or treat nausea and vomiting are known as complications of antiemetic treatment. Up to 30% of surgical patients may get postoperative nausea and vomiting (PONV) if they are left untreated. The incidence may reach 80% in people who are considered high-risk. Antiemetic medications are therefore often utilised during the perioperative phase. When morning sickness lasts for extended periods, antiemetic medications are a great assistance in managing the problem. This demonstrates how the need for antiemetics during pregnancy is driving the market's expansion.
(Source:https://www.aafp.org/pubs/afp/issues/2014/0615/p965.html )
(Source:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977925/ )
Market Dynamics of the Antiemetics Market
Key Drivers of the Antiemetics Market
- The rising prevalence of cancer will propel the market growth
The industry's growth will be supported by the rising number of cancer sufferers. Because cardiovascular ailments are on the rise, the industry is growing. In the twenty-first century, cancer is a significant social, public health, and economic issue. It accounts for about one in six fatalities (16.8%) and one in four deaths (22.8%) from noncommunicable diseases (NCDs) globally. Approximately 9–10 million people die from cancer each year. Lung and breast cancer are the two most common types, and their occurrence has increased significantly. Of the 2.3 million instances of breast cancer that were identified worldwide in 2021, 680,000 people died from the disease. Similarly, the prevalence of lung cancer is rising as a result of the increased smoking trend. According to research, smoking is the primary cause of 82% of occurrences of lung cancer. Antiemetics, commonly referred to as antinausea medications, are effective in preventing or minimizing nausea and vomiting, which are common adverse effects of cancer therapies.
(Source:https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21834 )
(Source:https://www.who.int/news-room/fact-sheets/detail/breast-cancer )
- Increasing the number of drug approvals and ongoing research activities significantly drives the market.
Antiemetic medication research, development, and approval processes include a large number of industry actors. By increasing financing, several government agencies seek to improve the healthcare system and further modify the dynamics of the market. The yearly New Drug Therapy Approvals Report provides information on the 55 innovative medications that CDER authorised in 2023. A unique drug's active component or ingredients have never received FDA approval before. Over the course of the forecast period, the launch and approval of such goods are expected to play a major role in driving market expansion. Five biosimilars were authorised by CDER in 2023, three of which were biosimilars for reference products for which there was no prior biosimilar. For 14 reference products, CDER has authorised 45 biosimilars thus far.
(Source:https://www.fda.gov/news-events/fda-voices/fda-approves-many-new-drugs-2023-will-benefit-patients-and-consumers )
• For instance, in March 2023, Taiho Pharmaceutical Co., Ltd. received authorization to market and manufacture Arokaris, a selective NK1 receptor antagonist antiemetic drug designed for gastrointestinal symptoms associated with cancer chemotherapy.
(Source:https://www.taiho.co.jp/en/release/2022/20220525.html )
Restraints of the Antiemetics Market
- High entry barriers for new players may hamper the market
One of the main issues preventing the industry from expanding is the high entry barriers for new companies. It is extremely difficult for SMEs to develop innovative items that may succeed in the market because of the existence of larger market participants. Additionally, buyers' switching costs and the public businesses' credibility play a major impact in the market condition. It is also very difficult for younger businesses to get into the market since these larger corporations have extensive distribution networks and work with all of the major hospitals and health facilities. Prominent corporations like Novartis AG and Pfizer Inc. have strong brand identities. As a result, consumers are reluctant to embrace novel items. Additionally, the large projects provide a variety of goods that are usually incomparable to those of the up-and-coming competitors.
How did COVID-19 impact the antiemetics drugs market?
The market for antiemetic medications has benefited from the COVID-19 epidemic. Antiemetics are increasingly being used to treat nausea and vomiting brought on by COVID-19 or any other treatment due to the rise in SARS-CoV-2 patients. In The International Journal of Clinical Practice, 2021, for example, research titled "Current Knowledge and Recent Advances in Intracellular Emetic Signalling System" noted that antiemetics were used far more frequently during COVID-19 to treat nausea and vomiting. Additionally, hospitalised COVID-19 patients who would be having open surgery and hence be more susceptible to nausea and vomiting were treated with it. Thus, the increase in the antiemetic medicine industry was positively influenced by the COVID-19 pandemic.
Opportunities of the Antiemetics Market
- Expanding surgical procedures is a significant opportunity for the market
Postoperative nausea and vomiting (PONV) is a typical side effect following surgery, regardless of size. As surgical procedures become more sophisticated and common, effective anti-emetic drugs are becoming increasingly important to lower the incidence of postoperative nausea and vomiting (PONV). Approximately 80% of patients with several risk factors experience it. Patient, anaesthetic, and surgical variables are among the several aetiologies of PONV. Research conducted in Ethiopia found that the incidence of postoperative nausea and vomiting (PONV) was 36.2%. Associated variables included a history of motion sickness, prior PONV episodes, prolonged anaesthesia, major surgery, and gynaecological procedures. Anti-emetics are in high demand in the market because of the rise in surgical procedures.
(Source:https://www.sciencedirect.com/science/article/pii/S2405857220300826 )
• For instance, according to a September 2020 published article titled "Estimation of the National Surgical Needs in India by Enumerating the Surgical Procedures in an Urban Community Under Universal Health Coverage," approximately 5,000 surgeries are deemed necessary to address the surgical burden of diseases for every 100,000 individuals in low- and middle-income countries (LMICs).
(Source:https://www.researchgate.net/publication/284040568_Disease_control_priorities_in_developing_countries )
We have various report editions of Antiemetics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Competitive Landscape: Antiemetics Market
Major market participants who are essential in determining consumer preferences and market dynamics have a major impact on the antiemetics market. These major players provide consumers with easy access to a vast array of wardrobe options through their extensive retail networks and online platforms. Product adoption has increased as a result of their strong worldwide presence and well-known brand, which has also increased consumer trust and loyalty. In addition, these industry titans never stop funding R&D, bringing cutting-edge styles, materials, and practical features to clothing wardrobes to meet changing customer demands and preferences. These big players' combined efforts have a big impact on the market’s future direction and level of competition.
Top Companies Market Share in Antiemetics Industry: (In no particular order of Rank)
- GlaxoSmithKline
- Merck
- Sanofi Aventis
- Bristol Myers Squibb
- Eli Lilly
- Pfizer
- Astellas
- Johnson & Johnson
- Baxter
- Cadila Pharmaceuticals Ltd.
- Cipla Ltd.
- Eagle Pharmaceuticals Inc.
- Fresenius SE and Co. KGaA
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Which Region will dominate the Market in 2024?
North America dominated the market with a share of xx% in 2024. The existence of major companies like Pfizer and GSK plc is probably going to increase the region's revenue share. Furthermore, it is expected that regional development would be fueled by the increasing number of antiemetics medication approvals in the area. Over the past 25 years, there has been a significant decrease in the occurrence of chemotherapy-induced nausea and vomiting thanks to the creation of increasingly potent antiemetic regimens. The only oral antiemetic drug authorised for use during pregnancy in Canada is a sustained-release formulation of pyridoxine hydrochloride and the antihistamine doxylamine succinate, which inhibits H1 receptors. This combination is advised as the first line of therapy. The US regulatory bodies have authorized the use of this combo product.
Which Region is Expanding at the Fastest CAGR?
The Asia Pacific market is expected to grow at a significant CAGR from 2024 to 2031. The region's market is anticipated to be supported by rising cancer and gastroenteritis incidence rates as well as the expanding availability of antiemetics. In the five years between 2020 and 2025, there will be a 12.8% rise in the number of cancer cases in India, according to research released by the National Library of Medicine in November 2022. Therefore, it is projected that over the projection period, regional growth will be driven by rising cancer occurrences along with expanding chemotherapy. Leading players in the market are constantly involved in a range of strategic activities designed to maintain and strengthen their position within the industry. These calculated actions help them stay in the market, but they also help them build and widen their commercial opportunities.
The current report Scope analyzes Antiemetics Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Antiemetics Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Antiemetics Market Analysis
Global Antiemetics Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Antiemetics Industry growth. Antiemetics market has been segmented with the help of its Drug Type, Application End-User, and others. Antiemetics market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Antiemetics Market Drug Type Segment Analysis
- Serotonin-Receptor Antagonists
- Dopamine Receptor Antagonists
According to cognitive market research, the Serotonin-receptor antagonists segment accounted for the largest market share of xx% in 2024 and is expected to witness the fastest growth during the forecast period. This segment includes drugs like Ondansetron (Zofran), Dolasetron (Anzemet), and Granisetron (Kytril). Both injectable and oral tablet forms are offered for these medications. The increased use of serotonin-receptor antagonist medications to reduce nausea and vomiting related to chemotherapy, radiation treatment, and anaesthesia, together with the rising global incidence of cancer, is responsible for the segment's larger revenue share and growth. The expansion of this market is fueled by the use of serotonin-receptor antagonists to treat nausea and vomiting that are occasionally caused by radiation therapy, chemotherapy, or surgery.
• For instance, in May 2022 article from the Canadian Institutes of Health Research highlighted the approval of Ondansetron, a 5-HT3 antagonist, in Canada for use as an antiemetic in managing nausea and vomiting associated with chemotherapy and post-operation scenarios.
(Source:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594936/ )
Antiemetics Market Share (%) by Drug Type in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Antiemetics Industry. Request a Free Sample PDF!
Antiemetics Market Drug Type Segment Analysis
- Gastroenteritis
- Post-Operative Surgery
- Chemotherapy
According to cognitive market research, the chemotherapy segment dominated the application segment in 2024 with a market share of xx%. The increasing number of cases of people suffering from cancer day by day is fueling the segment’s growth. The segment's larger revenue share is explained by the rising number of new product releases and the growing usage of antiemetics to treat chemotherapy-related nausea and vomiting. Patients undergoing mildly emetogenic chemotherapy are advised to take palonosetron on day 1 alone and dexamethasone on days 1-3 as a combination of two medications. Although the prevalence of vomiting has significantly decreased due to the introduction of novel antiemetic drugs, assessments reveal that between 30% and 60% of patients still have immediate or delayed nausea following chemotherapy. The higher revenue share of this industry may be ascribed to the growing usage of antiemetic medications to treat chemotherapy-related nausea and vomiting, as well as a rise in new product introductions in this field.
(Source:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046471/ )
• For instance, in May 2020, in Brazil, Helsinn, a Swiss pharmaceutical company, and Mundipharma introduced the hard capsule AKYNZEO for oral use. This drug is used to treat the nausea and vomiting induced by acute and delayed chemotherapy.
(Source:https://www.helsinn.com/news/helsinn-group-announces-akynzeo-fosnetupitantpalonosetron-injection-is-now-available-in-a-ready-to-use-vial-in-the-us/ )
• For instance, in September 2020, Sandoz, a Novartis division, launched generic Fosaprepitant, an anti-emetic drug used in preventing nausea and vomiting induced by chemotherapy in the United States, enhancing hospital offerings and strategically expanding its injectables portfolio.
(Source:https://www.cancer.gov/about-cancer/treatment/side-effects/nausea/nausea-hp-pdq )
Antiemetics Market Share (%) by Application in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Antiemetics End-User Segment Analysis
According to cognitive market research, the retail pharmacies segment dominated the market in 2024 with a revenue share of xx%. Retail pharmacies' convenience and product availability are expected to fuel the segment's expansion. The convenience and product availability offered by retail pharmacies are projected to fuel the segment's expansion. Over the course of the forecast period, there will likely be an increase in demand for these medications. In the antiemetic medicine market, generic equivalents are essential since they provide cheaper options than branded drugs. For example, branded and generic versions of the recently FDA-approved antiemetic Barhemsys are available. Antiemetic medications are essential for treating nausea and vomiting brought on by anaesthesia, according to the Association of Anaesthetists. Over the course of the projected period, it is also expected that the existence of several retail pharmacy chains worldwide, such as Rite Aid, Walgreens Boots Alliance, and CVS Pharmacy, will propel demand for these medications.
- Retail Pharmacy
- Hospital & Clinics
Author's Detail
David FullerSenior Analyst at Cognitive Market Research
I am working as a Senior Analyst with Cognitive Market Research in the areas of Industry Survey and Market Research/Analytics. I collaborate with CXOs, VPs, and other senior executives to understand their data needs and provide solutions and business strategy building.
I am working as a Senior Analyst with Cognitive Market Research in the areas of Industry Survey and Market Research/Analytics. I collaborate with CXOs, VPs, and other senior executives to understand their data needs and provide solutions and business strategy building. I fulfill data requirements with thorough research and analytics. ME and My research team provide intelligence on industry stats, market structure, company profiles/Competition Analysis, Forecast Mapping, and Recently started providing the COVID-19 Impact Analysis.
Specialties: Industry research, Company analysis, Location Strategy, Tech Research, Change Management, Process Improvement, Peer Group Benchmarking, Startup Ecosystem, Crypto Research, COVID19 Impact Analysis, etc.
Author's Conclusion
The drugs or medications which help to prevent and treat conditions such as nausea, and vomiting are referred to as antiemetic drugs. The expansion of this market is fueled by the use of serotonin-receptor antagonists to treat nausea and vomiting that are occasionally caused by radiation therapy, chemotherapy, or surgery. Over the course of the forecast period, there will likely be an increase in demand for these medications. In the antiemetic medicine market, generic equivalents are essential since they provide cheaper options than branded drugs. These major firms position themselves to take advantage of market opportunities, deal with obstacles, and strengthen their overall market position by carefully navigating the competitive landscape.
Frequently Asked Questions
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Antiemetics Market
Sources from Manufacturing & Construction Industry
-
https://www.epa.gov/regulatory-information-sector/construction-sector-naics-23
-
https://www.usace.army.mil/Missions/Civil-Works/Engineering-and-Construction/
-
https://www.abs.gov.au/statistics/industry/building-and-construction
-
https://business.gov.au/planning/industry-information/construction-industry
-
https://www.usitc.gov/research_and_analysis/tradeshifts/2021/footwear
Antiemetics Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Drug Type | Serotonin-Receptor Antagonists, Dopamine Receptor Antagonists |
| Application | Gastroenteritis, Post-Operative Surgery, Chemotherapy |
| End-User | Retail Pharmacy, Hospital & Clinics |
| List of Competitors | GlaxoSmithKline, Merck, Sanofi Aventis, Bristol Myers Squibb, Eli Lilly, Pfizer, Astellas, Johnson & Johnson, Baxter, Cadila Pharmaceuticals Ltd., Cipla Ltd., Eagle Pharmaceuticals Inc., Fresenius SE and Co. KGaA |
This chapter will help you gain GLOBAL Market Analysis of Antiemetics. Further deep in this chapter, you will be able to review Global Antiemetics Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Antiemetics Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Antiemetics Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Antiemetics Revenue Market Size By Region
-
-
1.3 Global Antiemetics Market Size By Drug Type 2019 -2031
-
1.3.1 Serotonin-Receptor Antagonists Market Size
-
1.3.2 Dopamine Receptor Antagonists Market Size
-
-
1.4 Global Antiemetics Market Size By Application 2019 -2031
-
1.4.1 Gastroenteritis Market Size
-
1.4.2 Post-Operative Surgery Market Size
-
1.4.3 Chemotherapy Market Size
-
-
1.5 Global Antiemetics Market Size By End-User 2019 -2031
-
1.5.1 Retail Pharmacy Market Size
-
1.5.2 Hospital & Clinics Market Size
-
-
1.6 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.7 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.7.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.7.2 Global Market Revenue Split By Drug Type
-
1.7.3 Global Market Revenue Split By Application
-
1.7.4 Global Market Revenue Split By End-User
-
1.7.5 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America Antiemetics Market Size 2019 - 2031
-
2.1.1 North America Antiemetics Market Size By Country 2019 - 2031
-
2.1.2 North America Antiemetics Market Size by Drug Type 2019 -2031
-
2.1.2.1 North America Serotonin-Receptor Antagonists Market Size
-
2.1.2.2 North America Dopamine Receptor Antagonists Market Size
-
-
2.1.3 North America Antiemetics Market Size by Application 2019 -2031
-
2.1.3.1 North America Gastroenteritis Market Size
-
2.1.3.2 North America Post-Operative Surgery Market Size
-
2.1.3.3 North America Chemotherapy Market Size
-
-
2.1.4 North America Antiemetics Market Size by End-User 2019 -2031
-
2.1.4.1 North America Retail Pharmacy Market Size
-
2.1.4.2 North America Hospital & Clinics Market Size
-
-
Chapter 3 Europe Market Analysis
-
3.1 Europe Antiemetics Market Size 2019 - 2031
-
3.1.1 Europe Antiemetics Market Size By Country 2019 - 2031
-
3.1.2 Europe Antiemetics Market Size by Drug Type 2019 -2031
-
3.1.2.1 Europe Serotonin-Receptor Antagonists Market Size
-
3.1.2.2 Europe Dopamine Receptor Antagonists Market Size
-
-
3.1.3 Europe Antiemetics Market Size by Application 2019 -2031
-
3.1.3.1 Europe Gastroenteritis Market Size
-
3.1.3.2 Europe Post-Operative Surgery Market Size
-
3.1.3.3 Europe Chemotherapy Market Size
-
-
3.1.4 Europe Antiemetics Market Size by End-User 2019 -2031
-
3.1.4.1 Europe Retail Pharmacy Market Size
-
3.1.4.2 Europe Hospital & Clinics Market Size
-
-
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Antiemetics Market Size 2019 - 2031
-
4.1.1 Asia Pacific Antiemetics Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Antiemetics Market Size by Drug Type 2019 -2031
-
4.1.2.1 Asia Pacific Serotonin-Receptor Antagonists Market Size
-
4.1.2.2 Asia Pacific Dopamine Receptor Antagonists Market Size
-
-
4.1.3 Asia Pacific Antiemetics Market Size by Application 2019 -2031
-
4.1.3.1 Asia Pacific Gastroenteritis Market Size
-
4.1.3.2 Asia Pacific Post-Operative Surgery Market Size
-
4.1.3.3 Asia Pacific Chemotherapy Market Size
-
-
4.1.4 Asia Pacific Antiemetics Market Size by End-User 2019 -2031
-
4.1.4.1 Asia Pacific Retail Pharmacy Market Size
-
4.1.4.2 Asia Pacific Hospital & Clinics Market Size
-
-
Chapter 5 South America Market Analysis
-
5.1 South America Antiemetics Market Size 2019 - 2031
-
5.1.1 South America Antiemetics Market Size By Country 2019 - 2031
-
5.1.2 South America Antiemetics Market Size by Drug Type 2019 -2031
-
5.1.2.1 South America Serotonin-Receptor Antagonists Market Size
-
5.1.2.2 South America Dopamine Receptor Antagonists Market Size
-
-
5.1.3 South America Antiemetics Market Size by Application 2019 -2031
-
5.1.3.1 South America Gastroenteritis Market Size
-
5.1.3.2 South America Post-Operative Surgery Market Size
-
5.1.3.3 South America Chemotherapy Market Size
-
-
5.1.4 South America Antiemetics Market Size by End-User 2019 -2031
-
5.1.4.1 South America Retail Pharmacy Market Size
-
5.1.4.2 South America Hospital & Clinics Market Size
-
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Antiemetics Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Antiemetics Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Antiemetics Market Size by Drug Type 2019 -2031
-
6.1.2.1 Middle East and Africa Serotonin-Receptor Antagonists Market Size
-
6.1.2.2 Middle East and Africa Dopamine Receptor Antagonists Market Size
-
-
6.1.3 Middle East and Africa Antiemetics Market Size by Application 2019 -2031
-
6.1.3.1 middle_east_and_africa_title} Gastroenteritis Market Size
-
6.1.3.2 middle_east_and_africa_title} Post-Operative Surgery Market Size
-
6.1.3.3 middle_east_and_africa_title} Chemotherapy Market Size
-
-
6.1.4 Middle East and Africa Antiemetics Market Size by End-User 2019 -2031
-
6.1.4.1 Middle East and Africa Retail Pharmacy Market Size
-
6.1.4.2 Middle East and Africa Hospital & Clinics Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Antiemetics Market Size by Drug Type 2019 -2031
-
7.1.2 Country 1Antiemetics Market Size by Application 2019 -2031
-
7.1.3 Country 1Antiemetics Market Size by End-User 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Antiemetics Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 GlaxoSmithKline
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Merck
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Sanofi Aventis
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Bristol Myers Squibb
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Eli Lilly
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Pfizer
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Astellas
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Johnson & Johnson
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Baxter
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Cadila Pharmaceuticals Ltd.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 Cipla Ltd.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
8.2.12 Eagle Pharmaceuticals Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.12.2 Business Overview
-
8.2.12.3 Financials (Subject to data availability)
-
8.2.12.4 Product Types Specification
-
8.2.12.5 Business Strategy
-
8.2.12.6 S.W.O.TAnalysis
-
-
8.2.13 Fresenius SE and Co. KGaA
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.13.2 Business Overview
-
8.2.13.3 Financials (Subject to data availability)
-
8.2.13.4 Product Types Specification
-
8.2.13.5 Business Strategy
-
8.2.13.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Drug Type Analysis 2019 -2031, will provide market size split by Drug Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Drug Type Analysis 2019 -2031
-
10.1 Serotonin-Receptor Antagonists
-
10.1.1 Global Antiemetics Revenue Market Size and Share by Serotonin-Receptor Antagonists 2019 -2031
-
-
10.2 Dopamine Receptor Antagonists
-
10.2.1 Global Antiemetics Revenue Market Size and Share by Dopamine Receptor Antagonists 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2019 -2031
-
11.1 Gastroenteritis
-
11.1.1 Global Antiemetics Revenue Market Size and Share by Gastroenteritis 2019 - 2031
-
-
11.2 Post-Operative Surgery
-
11.2.1 Global Antiemetics Revenue Market Size and Share by Post-Operative Surgery 2019 - 2031
-
-
11.3 Chemotherapy
-
11.3.1 Global Antiemetics Revenue Market Size and Share by Chemotherapy 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by End-User Analysis 2019 -2031
-
12.1 Retail Pharmacy
-
12.1.1 Global Antiemetics Revenue Market Size and Share by Retail Pharmacy 2019 -2031
-
-
12.2 Hospital & Clinics
-
12.2.1 Global Antiemetics Revenue Market Size and Share by Hospital & Clinics 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Antiemetics market
Chapter 13 Research Findings
-
13.1 Key Takeaways
-
13.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
13.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by David Fuller and Team
- 1.1 Antiemetics Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Antiemetics Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Antiemetics Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Antiemetics Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Antiemetics Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Antiemetics Market
Key Questions Answered By Antiemetics Market Report 2024
| Why Serotonin-Receptor Antagonists have a significant impact on Antiemetics market? |
| What are the key factors affecting the Serotonin-Receptor Antagonists and Dopamine Receptor Antagonists of Antiemetics Market? |
| What is the CAGR/Growth Rate of Gastroenteritis during the forecast period? |
| By type, which segment accounted for largest share of the global Antiemetics Market? |
| Which region is expected to dominate the global Antiemetics Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
